Back to all bills
HR 6089119th CongressIn Committee
Biomanufacturing Excellence Act of 2025
Introduced: Nov 18, 2025
Sponsor: Rep. Houlahan, Chrissy [D-PA-6] (D-Pennsylvania)
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Biomanufacturing Excellence Act of 2025 establishes a National Biopharmaceutical Center of Excellence, authorizes $120 million for FY 2026, and sets objectives, funding mechanisms, reporting, and intellectual‑property guidelines.
Key Points
- 1Creation of a National Biopharmaceutical Center of Excellence
- 2Funding: $120 million for FY 2026
- 3Objectives: technology development, workforce training, supply‑chain resilience
- 4Reporting requirements: initial, progress, and final reports
- 5Intellectual‑property guidelines and IP stewardship
Impact Areas
Biotechnology and biopharmaceutical industryResearchers and academic institutionsWorkforce development programsFederal agencies (HHS, NSF, NIH)National security and economic competitiveness
Generated by openai/gpt-oss-20b:free on Nov 19, 2025